Neo Nordisk halts production of Anagni compliance drug: 2 billion venture capital |

The decision of the Novo Nordisk pharmaceutical giant is followed by a notification of the global sales market by 8%.

Novo Nordisk reduces 9,000 jobs: What happens with an anti -objectic drug giant

From the valentine Joe

Decision of the giant pharmaceutical giant Novotec Rice Financement Week Market Contraction with 8% in Global Sales

Novo Nordisk - il colosso farmaceutico che nel 2023 era arrivato a essere la prima società europea per valore di Borsa e rappresentava da solo un quinto della crescita occupazionale danese - ha deciso di sospendere temporaneamente la produzione del farmaco anti obesità Wegovy nel sito di Anagni, in provincia di Frosinone. L’annuncio è stato dato nella sede di Unindustria Frosinone e la decisione fa seguito alla contrazione del mercato, con un calo dell’8% nelle vendite globali e una perdita di oltre 60 miliardi di euro di capitalizzazione in Borsa, riscontrata nelle scorse settimane.

Valentine Jaro

During the meeting, the presence of trade unions was stated that «Angney was a catalcon plant, which was presented as European strategic nodes a few weeks ago, is involved in the suspension of an original drug today, including the possible consequences of employment and industrial continuity.Unless the new production line and pure industrial extension plan are not guaranteed, the promise of elementary investment and employment growth of billions of euros is at risk."

For his place, the company back - we read in a copy - September was affected by Novor 10, yes, start changes to the resources and focus on resources. "

Author Valentina Iorio

The meeting declares that the main reason for crisis is lying to saturation of production and delay in climate change.

market searchCreated in the United States by the Introduction of the Mandate Decided by the Government of President Donald Trump is Decisive, in Which there is alSO anchecked proliferation of unauthorized copies"Semaglutide". This is added to the legal and patent difficulty of the patent of the ozmpic flowing at the beginning of Canada.